2012, Number 3
<< Back Next >>
Acta Med Cent 2012; 6 (3)
Evolution of children with septic shock according to the application of hemodynamic treatment
Bilbao GK, Cartaya IJM, González LW, García PJ, Martell BNL, Segredo MY
Language: Spanish
References: 20
Page:
PDF size: 60.40 Kb.
ABSTRACT
A cohort study was conducted in children diagnosed with septic shock and admitted to the Intensive Care Unit of the Jose Luis Miranda Pediatric University Hospital in Santa Clara, Villa Clara, during the period from January 1, 2004 to December 31, 2007, with the objective of identifying the influence of the hemodynamic treatment in their evolution. For that purpose, the treatment sustained in the guideline recommendations of the American College of Critical Care Medicine was applied. The cohort was composed of 132 patients with the diagnosis outlined above. The evolution was assessed according to discharge status – alive or deceased. The frequency of patients discharged alive increased significantly with increasing the amount of fluid administered in the first hour. Of all combinations of vasoactive drugs, dobutamine and epinephrine was associated with lower frequency of deaths. The development of the acute respiratory distress syndrome was not related to the amount of fluid administered in the first six hours; and the earlier the use of artificial ventilation, the lower the possibility of death, hence the impact of this measure on the favorable evolution of the patients.
REFERENCES
Carcillo JA, Task Force M, Fields AI. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med. 2002; 30: 1365-78.
Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference. Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6(1): 1-8.
Brierley J, Carcillo JA, Choong K, Cornel T. Clinical practice parameters for hemodiynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009; 37(2): 666-88.
Dellinger PR, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2008 jan; 34(1): 17-60.
Carlsen S, Perner A. Initial fluid resuscitation of patients with septic shock in the intensive care unit. Acta Anaesthesiol Scand. 2011 apr; 55(4): 394-400.
Montalván González G. Shock séptico en pediatría. REMI. 2007; 7(3): 68-71.
Wolfler A, Silvani P, Musicco M, Antonelli M, Salvo I. Incidence of and mortality due to sepsis , severe sepsis and septic shock in Italian Pediatric Intensive Care Units: a prospective national survey. Intensive Care Med. 2008; 34: 1690-7.
Solís C. ¿Qué hay de nuevo en sepsis? BSCP. Can Ped. 2007; 31(2): 21-32.
Mejía R, Sánchez C. Sepsis severa y choque séptico: guías del manejo basadas en la evidencia. Rev Med Postgrados Medicina. UNAH. 2008; 11(3): 197-201.
Montalván González G, López Torres O. Parámetros clínicos y soporte hemodinámico en el niño y neonato en shock séptico. REMI. 2009; 9(4): 100-9.
Rivers E, Nguyen B, Havstad S. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345: 1368-77.
Piacentini E, Ferrer R. Sepsis grave y shock séptico: Todo hecho, todo por hacer. Med Intensiva. 2012; 36(4): 245-6.
Godos T, Bogar L, Fitó J, Marjanek Z, Gartner B, Kiss K. Hemodynamic effects of different volume replacement therapies in sepsis. Infection. 2009; 37(Suppl III): 48.
Santos AO, Furtado SE, Villela NR, Buskela E. Microcirculatory effects of fluid therapy and dopamine ,associated or not to fluid therapy, in endotoxemic hamsters. Clin Hemorheol Microcirc. 2011; 47(1): 1-13.
Grela C, Menchaca A, Alberti M. Protocolo de tratamiento del shock séptico en pediatría. Arch Pediatr Urug. 2006; 77(4): 373-75.
Inwald DP, Tasker RC, Peters MJ, Nadel S. Emergency management of children with severe sepsis in the United Kingdom: the results of the Paediatric Intensive Care Society sepsis audit. Arch Dis Child. 2009 may; 94(5): 348-53.
Doldán O. Shock Séptico en Pediatría: Enfoque Terapéutico. Pediatr. 2008; 35(2): 106- 11.
De Backer P, Biston J, Devriendt D. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010; 362: 779-89.
Irazuzta J, Sullivan KJ, Garcia PC, Piva JP. Pharmacologic support of id children in septic shock. J Pediatr (Rio J). 2007; 83(2 Suppl): 36-45.
Theilen U, Wilson L, Wilson G, Beattie JO, Qureshi S, Simpson D, Management of invasive meningococcal disease in children and young people. BMJ. 2008 jun 14; 336(7657): 1367-70.